SINTX Technologies, a leading manufacturing company, has been granted $2 million by the National Institutes of Health (NIH) to advance the development of a groundbreaking 3D-printed composite spinal implant. This prestigious grant marks the fourth NIH grant awarded to SINTX, following the successful Phase I award received in September 2021.
The primary objective of SINTX is to create 3DP SN-PEEK spinal implants that harness the benefits of polyetheretherketone while incorporating the antibacterial and osteoconductive properties of silicon nitride. Leveraging state-of-the-art and cost-effective 3D printing technologies, the company aims to revolutionize the field of spinal implants.
Over the next two years, SINTX will collaborate closely with the esteemed University of Pennsylvania School of Veterinary Medicine to bring this visionary project to life. The allocated NIH grant will provide crucial resources for material acquisition, testing, and trials conducted at both SINTX and Penn Vet.
A successful execution of the Phase II grant application objectives will empower SINTX to gather a substantial amount of benchtop and large animal in vivo data. This data is essential for the company's future pursuit of FDA regulatory clearance through the highly regarded 510(k) pathway.